NeuMoDx Molecular Announces FDA 510(k) Clearance for its N288 Molecular System and GBS Assay

NeuMoDx Molecular, a sample-to-result molecular diagnostic company focused on central laboratory customers, announced today it has received FDA 510(k) clearance for its NeuMoDx™ 288 Molecular System and its NeuMoDx™ GBS Assay.